I am a
Home I AM A Search Login

Papers of the Week

Papers: 26 Feb 2022 - 4 Mar 2022

Pharmacology/Drug Development

2022 Feb 28

Clin J Pain

Efficacy and Safety of a New Sustained-released Pregabalin Formulation Compared with Immediate-release Pregabalin in Patients with Peripheral Neuropathic Pain: A Randomized Non-inferiority Phase 3 Trial.


Han K A, Lee Y H, Son H-S, Song K-H, Kim S Y, Chung C H, Jang H C, Lee K-W, Cha B Y, Song K-H, Ko Y K, Lee P-B, Kim B J, Kim S, An T, Kim Y-C
Clin J Pain. 2022 Feb 28.
PMID: 35220330.


This study investigated whether a new sustained-release (SR) pregabalin formulation is non-inferior to immediate-release (IR) pregabalin in alleviating peripheral neuropathic pain in Korean patients.